# Bioventus Inc.: Form 8-K, filed Nov 17, 2025

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2025-11-17
- Accepted by EDGAR: Nov 17, 2025, 17:04 ET
- Period: 2025-11-14
- Accession: 0001665988-25-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/bvs-20251114.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/bvs-20251114.htm

Filed Nov 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001665988-25-000032. Last ingested by Listed: Nov 14, 2026, 17:43 ET. No prices; not investment advice.
